H2 | Is your BOTOX® authentic and FDA approved for use in US? |
H2 | Notify your eligible patients to enroll in the BOTOX® Savings Program |
H2 | See key information in a single location |
H2 | Made for your team |
H2 | Download clinical, office, and patient resources |
H2 | Assistance from AbbVie experts |
H3 | BOTOX® IMPORTANT INFORMATION |
H3 | IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING |
H3 | INDICATIONS |
H3 | Adult Bladder Dysfunction |
H3 | Pediatric Detrusor Overactivity Associated With a Neurologic Condition |
H3 | Chronic Migraine |
H3 | Limitations of Use |
H3 | Spasticity |
H3 | Limitations of Use Texto duplicado |
H3 | Cervical Dystonia |
H3 | Blepharospasm and Strabismus |
H3 | Primary Axillary Hyperhidrosis |
H3 | Limitations of Use Texto duplicado |
H3 | IMPORTANT SAFETY INFORMATION (continued) |
H3 | CONTRAINDICATIONS |
H3 | WARNINGS AND PRECAUTIONS |
H3 | Serious Adverse Reactions With Unapproved Use |
H3 | Hypersensitivity Reactions |
H3 | Increased Risk of Clinically Significant Effects With Preexisting Neuromuscular Disorders |
H3 | Dysphagia and Breathing Difficulties |
H3 | Pulmonary Effects of BOTOX in Patients With Compromised Respiratory Status Treated for Spasticity or for Detrusor Overactivity Associated With a Neurologic Condition |
H3 | Corneal Exposure and Ulceration in Patients Treated With BOTOX for Blepharospasm |
H3 | Retrobulbar Hemorrhages in Patients Treated With BOTOX for Strabismus |
H3 | Bronchitis and Upper Respiratory Tract Infections in Patients Treated for Spasticity |
H3 | Autonomic Dysreflexia in Patients Treated for Detrusor Overactivity Associated With a Neurologic Condition |
H3 | Urinary Tract Infections in Patients With Overactive Bladder |
H3 | Urinary Retention in Adults Treated for Bladder Dysfunction |
H3 | Human Albumin and Transmission of Viral Diseases |
H3 | ADVERSE REACTIONS |
H3 | Overactive Bladder |
H3 | Adult Detrusor Overactivity Associated With a Neurologic Condition |
H3 | Pediatric Detrusor Overactivity Associated With a Neurologic Condition Texto duplicado |
H3 | Chronic Migraine Texto duplicado |
H3 | Adult Upper Limb Spasticity |
H3 | Adult Lower Limb Spasticity |
H3 | Pediatric Upper Limb Spasticity |
H3 | Pediatric Lower Limb Spasticity |
H3 | Cervical Dystonia Texto duplicado |
H3 | Blepharospasm |
H3 | Strabismus |
H3 | Primary Axillary Hyperhidrosis Texto duplicado |
H3 | Postmarketing Experience |
H3 | DRUG INTERACTIONS |
H3 | IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Texto duplicado |
H3 | IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Texto duplicado |
H3 | IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Texto duplicado |
H3 | IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Texto duplicado |
H3 | BOTOX® IMPORTANT INFORMATION Texto duplicado |
H3 | IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING Texto duplicado |
H3 | INDICATIONS Texto duplicado |
H3 | Adult Bladder Dysfunction Texto duplicado |
H3 | Pediatric Detrusor Overactivity Associated With a Neurologic Condition Texto duplicado |
H3 | Chronic Migraine Texto duplicado |
H3 | Limitations of Use Texto duplicado |
H3 | Spasticity Texto duplicado |
H3 | Limitations of Use Texto duplicado |
H3 | Cervical Dystonia Texto duplicado |
H3 | Blepharospasm and Strabismus Texto duplicado |
H3 | Primary Axillary Hyperhidrosis Texto duplicado |
H3 | Limitations of Use Texto duplicado |
H3 | IMPORTANT SAFETY INFORMATION (continued) Texto duplicado |
H3 | CONTRAINDICATIONS Texto duplicado |
H3 | WARNINGS AND PRECAUTIONS Texto duplicado |
H3 | Serious Adverse Reactions With Unapproved Use Texto duplicado |
H3 | Hypersensitivity Reactions Texto duplicado |
H3 | Increased Risk of Clinically Significant Effects With Preexisting Neuromuscular Disorders Texto duplicado |
H3 | Dysphagia and Breathing Difficulties Texto duplicado |
H3 | Pulmonary Effects of BOTOX in Patients With Compromised Respiratory Status Treated for Spasticity or for Detrusor Overactivity Associated With a Neurologic Condition Texto duplicado |
H3 | Corneal Exposure and Ulceration in Patients Treated With BOTOX for Blepharospasm Texto duplicado |
H3 | Retrobulbar Hemorrhages in Patients Treated With BOTOX for Strabismus Texto duplicado |
H3 | Bronchitis and Upper Respiratory Tract Infections in Patients Treated for Spasticity Texto duplicado |
H3 | Autonomic Dysreflexia in Patients Treated for Detrusor Overactivity Associated With a Neurologic Condition Texto duplicado |
H3 | Urinary Tract Infections in Patients With Overactive Bladder Texto duplicado |
H3 | Urinary Retention in Adults Treated for Bladder Dysfunction Texto duplicado |
H3 | Human Albumin and Transmission of Viral Diseases Texto duplicado |
H3 | ADVERSE REACTIONS Texto duplicado |
H3 | Overactive Bladder Texto duplicado |
H3 | Adult Detrusor Overactivity Associated With a Neurologic Condition Texto duplicado |
H3 | Pediatric Detrusor Overactivity Associated With a Neurologic Condition Texto duplicado |
H3 | Chronic Migraine Texto duplicado |
H3 | Adult Upper Limb Spasticity Texto duplicado |
H3 | Adult Lower Limb Spasticity Texto duplicado |
H3 | Pediatric Upper Limb Spasticity Texto duplicado |
H3 | Pediatric Lower Limb Spasticity Texto duplicado |
H3 | Cervical Dystonia Texto duplicado |
H3 | Blepharospasm Texto duplicado |
H3 | Strabismus Texto duplicado |
H3 | Primary Axillary Hyperhidrosis Texto duplicado |
H3 | Postmarketing Experience Texto duplicado |
H3 | DRUG INTERACTIONS Texto duplicado |
(Deseable)